文献速递妇科

使用卫生棉条采集和甲基化DNA标志物检测子宫内膜癌

Detection of endometrial cancer using tampon-based collection and methylated DNA markers.
PubMed 文献 · Gynecol Oncol · 2023-05-02

研究通过降低代表性亚硫酸氢盐测序发现子宫内膜癌(EC)差异甲基化区域,并在独立组织中验证甲基化DNA标志物(MDM)。在100例EC与92例良性子宫内膜对照中,28-MDM面板在PBS/EDTA棉条缓冲液中达到96%特异度和82%敏感度(AUC 0.91)。作者认为基于棉条的EC MDM检测需开展更大规模研究。

要点

  • 28-MDM面板在棉条采集的阴道液中区分EC与良性子宫内膜,PBS/EDTA缓冲液敏感度82%、特异度96%。
  • 发现阶段通过RRBS筛选出33个符合组织性能标准的候选MDM。
  • 作者认为基于棉条的EC MDM检测需开展更大规模研究。

核心结论

  • 下一代甲基化组测序、严格过滤标准和独立验证产生了优异的EC候选MDM。
  • EC相关MDM在棉条采集的阴道液中表现出有前景的高敏感度和特异度;添加EDTA的PBS棉条缓冲液提高了敏感度。
  • 作者认为需开展更大规模的基于棉条的EC MDM检测研究。

研究设计与样本

  • 发现阶段:对冷冻EC、良性子宫内膜(BE)和良性宫颈阴道(BCV)组织DNA行降低代表性亚硫酸氢盐测序(RRBS)以识别差异甲基化区域(DMR)。
  • 候选DMR基于受试者工作特征(ROC)区分度、癌症与对照间甲基化水平倍数变化及背景CpG甲基化缺失进行选择。
  • MDM验证:在独立EC和BE福尔马林固定石蜡包埋(FFPE)组织集DNA上用qMSP进行。
  • 棉条试点:年龄≥45岁伴异常子宫出血(AUB)或绝经后出血(PMB)或任何年龄经活检证实EC的女性,在临床指示的子宫内膜取样或子宫切除术前使用棉条自采阴道液。
  • 阴道液DNA通过qMSP检测EC相关MDM;采用随机森林建模分析生成潜在疾病的预测概率,结果进行500倍计算机交叉验证。

主要发现

  • 33个候选MDM在组织中符合性能标准。
  • 棉条试点中,100例EC病例按绝经状态和棉条采集日期与92例BE对照进行频数匹配。
  • 28-MDM面板高度区分EC与BE:特异度96%(95%CI 89-99%),敏感度76%(66-84%),AUC 0.88。
  • 在PBS/EDTA棉条缓冲液中,该面板特异度96%(95%CI 87-99%),敏感度82%(70-91%),AUC 0.91。

关键数值与推荐

  • 28-MDM面板在PBS/EDTA棉条缓冲液中检测EC:特异度96%(95%CI 87-99%),敏感度82%(70-91%),AUC 0.91。
  • 28-MDM面板在(原文未指明缓冲液条件)中检测EC:特异度96%(95%CI 89-99%),敏感度76%(66-84%),AUC 0.88。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 作者认为需开展更大规模的基于棉条的EC MDM检测研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Alterations in DNA methylation are early events in endometrial cancer (EC) development and may have utility in EC detection via tampon-collected vaginal fluid. METHODS: For discovery, DNA from frozen EC, benign endometrium (BE), and benign cervicovaginal (BCV) tissues underwent reduced representation bisulfite sequencing (RRBS) to identify differentially methylated regions (DMRs). Candidate DMRs were selected based on receiver operating characteristic (ROC) discrimination, methylation level fold-change between cancers and controls, and absence of background CpG methylation. Methylated DNA marker (MDM) validation was performed using qMSP on DNA from independent EC and BE FFPE tissue sets. Women ≥45 years of age with abnormal uterine bleeding (AUB) or postmenopausal bleeding (PMB) or any age with biopsy-proven EC self-collected vaginal fluid using a tampon prior to clinically indicated endometrial sampling or hysterectomy. Vaginal fluid DNA was assayed by qMSP for EC-associated MDMs. Random forest modeling analysis was performed to generate predictive probability of underlying disease; results were 500-fold in-silico cross-validated. RESULTS: Thirty-three candidate MDMs met performance criteria in tissue. For the tampon pilot, 100 EC cases were frequency matched by menopausal status and tampon collection date to 92 BE controls. A 28-MDM panel highly discriminated between EC and BE (96% (95%CI 89-99%) specificity; 76% (66-84%) sensitivity (AUC 0.88). In PBS/EDTA tampon buffer, the panel yielded 96% (95% CI 87-99%) specificity and 82% (70-91%) sensitivity (AUC 0.91). CONCLUSION: Next generation methylome sequencing, stringent filtering criteria, and independent validation yielded excellent candidate MDMs for EC. EC-associated MDMs performed with promisingly high sensitivity and specificity in tampon-collected vaginal fluid; PBS-based tampon buffer with added EDTA improved sensitivity. Larger tampon-based EC MDM testing studies are warranted.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bakkum-Gamez JN, Sherman ME, Slettedahl SW, et al. Detection of endometrial cancer using tampon-based collection and methylated DNA markers. Gynecol Oncol. 2023. PMID: 37141817. doi:10.1016/j.ygyno.2023.04.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。